Ullem Scott B. 4
4 · Edwards Lifesciences Corp · Filed Dec 9, 2025
Insider Transaction Report
Form 4
Ullem Scott B.
CVP, Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-09$59.26/sh+7,700$456,277→ 47,598 total - Sale
Common Stock
2025-12-09$84.47/sh−7,700$650,412→ 39,898 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2025-12-09−7,700→ 39,000 totalExercise: $59.26From: 2020-05-08Exp: 2026-05-07→ Common Stock (7,700 underlying)
Holdings
- 266,318(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 29, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $84.09 to $85.07. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.